Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban versus enoxaparin/warfarin for planned electrical cardioversion in nonvalvular atrial fibrillation
NL-OMON40676Phase 3Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Atrial fibrillation (AFib) comparing Edoxaban arm with Enoxaparin/warfarin followed by warfarin arm (2 arms). Started Dec 2014; status: active, not recruiting.
02
Drugs
edoxabanwarfarinenoxaparin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON40676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40676.